The EMA grants Orphan Medicinal Product status to Verastem's (NASDAQ:VSTM) small molecule inhibitor VS-6063 for the treatment of mesothelioma. The designation gives the drug a leg up in terms of market exclusivity upon approval and opens the door for EMA assistance throughout clinical development. (PR)
The EMA grants Orphan Medicinal Product status to Verastem's (NASDAQ:VSTM) small molecule...
Recommended For You
More Trending News
About VSTM Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| VSTM | - | - |
| Verastem, Inc. | ||